百胜中国(YUMC.US)盘前涨超5%开盘势续创历史新高 传明日起港股招股
格隆汇8月31日丨上周五盘中创出历史新高价56.94美元的百胜中国(YUMC.US)今日盘前涨5.29%报59.49美元,开盘势将再创历史新高。据SEC文件显示,百胜中国(9987.HK)已通过上市聆讯,其中国际发售4020万股,香港发售170万股。最高发售价每股468港元,拟募资约25亿美元(约193.8亿港元),一手50股,入场费23635.8港元。另有消息称,百胜中国港股明天(9月1日)起招股,估值近2000亿,周五(9月4日)截止认购,预计9月4日定价,股份预期于9月10日上市。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.